Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$3.29M Sell
66,168
-30,087
-31% -$1.52M ﹤0.01% 2433
2014
Q2
$4.78M Buy
96,255
+67,009
+229% +$3.08M ﹤0.01% 2007
2014
Q1
$1.28M Sell
29,246
-4,332
-13% -$170K ﹤0.01% 3238
2013
Q4
$1.16M Sell
33,578
-7,760
-19% -$291K ﹤0.01% 3376
2013
Q3
$1.7M Sell
41,338
-98,966
-71% -$3.73M ﹤0.01% 2758
2013
Q2
$4.96M Buy
+140,304
New +$4.68M 0.01% 1626

Other funds holding CAVM

UBS's CAVM Position: Q3 2014 in Review

UBS reduced its Cavium, Inc. (CAVM) stake by 31% in Q3 2014, selling an estimated $1.52M and leaving 66,168 shares worth $3.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2433.

UBS first reported a position in CAVM in Q2 2013 and has held it in 6 quarters since. The position peaked at $4.96M in Q2 2013. 201 funds tracked by Wall St. Rank hold CAVM as of Q3 2014.

  • UBS held 66,168 shares of Cavium, Inc. worth $3.29M as of Q3 2014.
  • UBS sold 30,087 Cavium, Inc. shares in Q3 2014, an estimated $1.52M.
  • Cavium, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2433 holding.
  • UBS first reported a position in Cavium, Inc. in Q2 2013 and has held it in 6 quarters since.
  • UBS's Cavium, Inc. position peaked at $4.96M in Q2 2013.
  • 201 funds tracked by Wall St. Rank held Cavium, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.